文献速递妇科生殖医学

宫腔镜子宫内膜局灶切除术联合左炔诺孕酮宫内节育器置入作为不典型子宫内膜增生与早期子宫内膜癌的保留生育治疗:一项回顾性研究

Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
PubMed 文献 · J Minim Invasive Gynecol · 2018-07-11

意大利那不勒斯大学回顾性分析2007至2017年69例年轻不典型子宫内膜增生(55例)或早期子宫内膜癌(14例)患者,采用宫腔镜病灶切除联合左炔诺孕酮宫内节育器(LNG-IUD)保留生育治疗并随访24个月;完全缓解率分别为92.7%和78.6%,25例取出LNG-IUD者中10例(40%)自然受孕分娩。

要点

  • 早期子宫内膜癌14例中11例(78.6%)完全缓解,2例(18.2%)复发。
  • 不典型子宫内膜增生55例中51例(92.7%)完全缓解,2例(3.9%)复发。
  • 取出LNG-IUD的25例中10例(40%)自然受孕并分娩。

核心结论

  • 宫腔镜切除联合LNG-IUD治疗早期子宫内膜癌和不典型子宫内膜增生的缓解率与活产率与文献报道的单纯孕激素治疗相似,但复发率明显更低。
  • 作者主张将这一联合方案作为早期子宫内膜癌和不典型子宫内膜增生患者保留生育的替代选择。

研究设计与样本

  • 回顾性病例系列(加拿大任务组分类II-3),纳入2007至2017年意大利那不勒斯大学Federico II连续诊治的69例患者。
  • 早期子宫内膜癌14例,不典型子宫内膜增生55例;所有患者术后置入LNG-IUD,随访24个月并行系列宫腔镜活检。

主要发现

  • 早期子宫内膜癌14例中11例(78.6%)完全缓解,其中2例(18.2%)随后复发;1例(7.1%)部分缓解;2例(14.3%)无缓解(1例疾病稳定、1例进展)。
  • 不典型子宫内膜增生55例中51例(92.7%)完全缓解,其中2例(3.9%)随后复发;3例(5.5%)部分缓解;仅1例(1.8%)无缓解且疾病稳定。
  • 25例取出LNG-IUD的患者中,10例(40%)在随访最后12个月内自然受孕后分娩。

临床怎么用

  • 作者主张将宫腔镜切除联合LNG-IUD作为早期子宫内膜癌和不典型子宫内膜增生患者保留生育的替代选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To evaluate safety and effectiveness of the combination of hysteroscopic endometrial focal resection with levonorgestrel-releasing intrauterine device (LNG-IUD) for International Federation of Gynecology and Obstetrics stage IA G1 early endometrial cancer (EEC) and atypical endometrial hyperplasia (AEH) in young women to preserve their fertility. DESIGN: Retrospective case series (Canadian Task Force classification II-3). SETTING: University Federico II, Naples, Italy. PATIENTS: The medical records of 69 consecutive patients treated from 2007 to 2017 with diagnosis of EEC (n = 14) or AEH (n = 55) meeting inclusion criteria were reviewed. INTERVENTIONS: Patients with focal EEC were treated by hysteroscopic resection of the lesion according to Mazzon's technique; patients with AEH were treated by superficial endometrial resection, preserving the basal layer of the endometrium. An LNG-IUD was inserted in all patients after surgery. Patients were followed for 24 months with serial hysteroscopic biopsies. MEASUREMENTS AND MAIN RESULTS: Rates of response, live birth, and recurrence were assessed. Of the 14 patients with EEC, 11 (78.6%) achieved a complete response, 2 (18.2%) of whom had subsequent relapse, 1 (7.1%) showed partial response, whereas 2 (14.3%) were nonresponders (1 stable disease and 1 progression). Of the 55 patients with AEH, 51 (92.7%) achieved a complete response, 2 (3.9%) of whom had subsequent relapse, 3 (5.5%) showed partial response, whereas only 1 (1.8%) was nonresponder with stable disease. Among 25 patients who had removed the LNG-IUD, 10 (40%) gave birth after natural conception in the last 12 months of follow-up. CONCLUSION: The combination of hysteroscopic resection with an LNG-IUD as fertility-sparing treatment of EEC and AEH showed similar response and live birth rates compared with those reported in literature for progestins alone, but with considerably lower relapse rate. We advocate the use of this combined approach as an alternative fertility-sparing option in patients with ECC and AEH.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Giampaolino P, Di Spiezio Sardo A, Mollo A, et al. Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study. J Minim Invasive Gynecol. 2018. PMID: 30017893. doi:10.1016/j.jmig.2018.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。